Twist、上皮钙粘连素、神经钙粘连素mRNA及蛋白在胃癌中的表达及其意义
|
摘要
背景与目的
最早在研究果蝇发育过程中发现,Twist参与调节多种发育过程,尤其在早期中胚层的形成方面起重要作用。1996年人类Twist基因被成功克隆,定位于7p21.2,编码203个氨基酸,分子量约28Kd。Twist蛋白是具有碱螺旋-环-螺旋(basic helix-loop-helix ,bHLH)结构的转录因子家族成员,其可以与另外一个同源或异源的bHLH因子结合,形成二联DNA结合域,特异性地结合E-box盒,从而激活或抑制特异性的靶基因转录。
近年来的研究表明Twist是个新的癌基因,它可以通过p53依赖与非依赖的途径参与细胞的凋亡抵抗。目前研究表明,Twist过表达在肿瘤的发生、侵袭转移中发挥重要作用,但是其中的具体机制尚不清楚。有关Twist在胃癌发生、发展中的作用尚无深入的研究。
上皮细胞间质转型( epithelial-mesenchymal transitions, EMT)是具有极性的上皮细胞转换成为具有活动能力的间质细胞并获得侵袭和迁移能力的过程,它存在于人体多个生理和病理过程中。EMT的发生涉及到多个信号转导通路和复杂的分子机制,与钙连接素、生长因子、转录因子、微环境等有关。EMT与肿瘤细胞的侵袭和转移关系密切。上皮钙粘连素(E-cadherin,E-cad)和神经钙粘连素(N-cadherin,N-cad)都是钙粘连素家族的重要成员,参与细胞间粘附。E-cadherin是影响肿瘤浸润转移较为重要的分子,其丢失可导致肿瘤细胞脱落与转移,与E-cadherin不同,N-cadherin可促进肿瘤浸润转移。Twist, E-cadherin, N-cadherin都是EMT的重要分子。
基于上述考虑,本实验采用逆转录-聚合酶链反应(reverse transcription polymerase chain reaction, RT-PCR )、免疫组织化学技术对胃癌组织及其癌旁组织中Twist, E-cadherin,N-cadheri n的表达进行检测,为阐明胃癌的致病机制和防治提供实验基础和理论依据。
方法
1.采用RT-PCR方法检测58例人胃癌组织及58例相应癌旁组织中Twist, E-cadherin, N-cadherin mRNA的表达;
2.采用免疫组织化学方法检测58例人胃癌组织及癌旁组织中Twist, E-cadherin, N-cadherin蛋白表达;
3.采用SPSS 10.0统计软件进行统计学处理。采用t检验对计量资料进行统计学分析,采用x2检验对计数资料进行统计学分析,用相关进行相关分析,检验水准α=0.05.
结果
1.人胃癌组织RT-PCR方法检测结果显示: Twist, E-cadherin, N-cadherin分别于210bp、132bp、156bp处显带,为阳性表达。Twist, N-cadherin mRNA在胃癌组织中的阳性率分别为72.41%, 48.28%;明显高于癌旁组织的31.03%, 13.79%;E-cadherin mRNA在胃癌组织的阳性表达率为39.66%,明显低于癌旁组织的84.48%;差异有统计学意义(P<0.01)。
2.人胃癌组织免疫组织化学染色结果显示: Twist, N-cadherin蛋白在胃癌组织中的阳性表达率分别为75.9%,44.8%;明显高于癌旁组织的32.8% ,12.1% ;E-cadherin蛋白在胃癌组织中的阳性表达率为36.2%,明显低于癌旁组织的91.3%;差异有统计学意义(P<0.01)。
结论
1. Twist、N-cadherin mRNA及蛋白在胃癌中过表达,E-cadherin mRNA及蛋白在胃癌中低表达;可能与胃癌发生发展有关;
2. Twist, E-cadherin, N-cadherin与胃癌的浸润转移有关,三者共同参与了EMT过程。
3.联合检测三项指标对于进一步预测胃癌的转移、判断其预后具有重要意义。
Background and objective:
Twist was originally identified in Drosophila as a protein involved in the regulation of diverse developmental processes, particularly in the formation of mesoderm.The human Twist gene is located at chromosome 7p21.2.The Twist protein consists of 201 amino acids and its molecular weight is about 28kd.Twist protein is a transcription factor that belongs to the family of basic helix-loop-helix(bHLH)protein.The mechanism of bHLH molecules require that they either homo-or heterodimerize with other bHLH molecules,form a bipartite DNA-binding domain and bind to a conserved E-box region on the promoter of genes which activate or inhibit transcription.
Recent studies have shown that Twist is a potential oncogene and be involved in the protection of apoptosis via both p53-dependent and independent pathways.To date several studies revealed that Twist played crucial roles in tumorigenesis, invasion and metastasis,but its accurate molecular mechanisms remain unclear.However,there have been little available data on the role of Twist in the development and progession of gastric cancer;the molecule involved in the regulation of Twist and its mechanism was still unclear. We researched for the molecule involved in the regulation of Twist and its mechanisms.
Epithelial-mesenchymal transitions (EMT) is a process that epithelial cell layers lose polarity and acquire expression of mesenchymal components and manifest a migratory phenotype. It exists in many physiological and pathological p rocesses in human body. The progress of EMT involves a number of signal transduction pathways and complex molecular mechanisms, and is related to calcium catenin,growth factors, transcription factors, microenvironment, and so on. EMT play an important role in tumor metastasis. E-cadherin and N-cadherin are members of the family of transmembrane glycoproteins expressed on epithelial cells and are responsible for calciumdependent cell -to-celladhesion. E-cad can lead to Loss of cell adhesion,cell adhesion may contribute to loss of contact inhibition of growth, which is an early step in the neoplastic process.Furthermore, loss of cadherin activity may result in cancer cell detachment and metastasis.It has been suggested that, unlike E-cadherin, N-cadherin may promote invasion and metastasis of carcinoma. Twist,E- and N-cadherin are important molecules that modulate cell migration and tumor,invasion.
According to above metioned consider, in this study, Reverse transcription polymerase chain reaction (RT-PCR) technique and immunohistochemical method were used to detect the expression of Twist,E-cadherin and N-cadherin in gastric cancer. So that to provide experimental evidence for elucidating the etiopathogenesis, treatment and prevention in gastric cancer.
Methods:
1 .Reverse transcription polymerase chain reaction (RT- PCR) technique was used to examine the expressions of Twist,E-cadherin and N-cadherin mRNA in the 58 gastric cancer tissues and their 58 non-tumorous gastric tissues.
2. Supervision TM immunohistochemical method was used to detect the expression of Twist,E-cadherin and N-cadherin proteins in 58 cases of gastric cancer tissues and their non-tumorous gastric tissues.
3. SPSS 10.0 statistical software was applied to statistics the date. To categorical variable the sperman correlation analysis were used to analyze. To numerical variable the date was expressed with x士s and t test was used to compare these datas. The significant level was a =0.05.
Results:
1 .The positive expression of Twist,E-cadherin and N-cadherin locate in land 210bp,132bp,156bp. The positive expression of Twist,E-cadherin and N-cadherin mRNAs were 72.41%,39.66%, 48.28% in gastric cancer tissues, and were 31.03%, 84.48%, 13.79% in non-tumorous gastric tissue, respectively. (P<0.01).
2. The positive expression rates of Twist,E-cadherin and N-cadherin proteins were 75.9%,36.2%,44.8% in gastric cancer tissues, and were 32.8%,91.3%,12.1% in non-tumorous gastric tissue,respectively. (P<0.01).
Conclusions:
1 .The higher expressions of Twist,N-cadherin and the lower expression of E-cadherin in gastric cancer had the close relation to carcinogenesis of gastric cancer.
2. The expressions of Twist,E-cadherin and N-cadherin are related with the invasion,metastasis of gastric cancer,the genes of Twist,E-cadherin and N-cadherin participate with process of EMT together.
3.United measurement of the expression of Twist,E-cadherin and N-cadherin genes is helpful to predict metastasis of gastric cancer and to judge prognosis of gastric cancer.
最早在研究果蝇发育过程中发现,Twist参与调节多种发育过程,尤其在早期中胚层的形成方面起重要作用。1996年人类Twist基因被成功克隆,定位于7p21.2,编码203个氨基酸,分子量约28Kd。Twist蛋白是具有碱螺旋-环-螺旋(basic helix-loop-helix ,bHLH)结构的转录因子家族成员,其可以与另外一个同源或异源的bHLH因子结合,形成二联DNA结合域,特异性地结合E-box盒,从而激活或抑制特异性的靶基因转录。
近年来的研究表明Twist是个新的癌基因,它可以通过p53依赖与非依赖的途径参与细胞的凋亡抵抗。目前研究表明,Twist过表达在肿瘤的发生、侵袭转移中发挥重要作用,但是其中的具体机制尚不清楚。有关Twist在胃癌发生、发展中的作用尚无深入的研究。
上皮细胞间质转型( epithelial-mesenchymal transitions, EMT)是具有极性的上皮细胞转换成为具有活动能力的间质细胞并获得侵袭和迁移能力的过程,它存在于人体多个生理和病理过程中。EMT的发生涉及到多个信号转导通路和复杂的分子机制,与钙连接素、生长因子、转录因子、微环境等有关。EMT与肿瘤细胞的侵袭和转移关系密切。上皮钙粘连素(E-cadherin,E-cad)和神经钙粘连素(N-cadherin,N-cad)都是钙粘连素家族的重要成员,参与细胞间粘附。E-cadherin是影响肿瘤浸润转移较为重要的分子,其丢失可导致肿瘤细胞脱落与转移,与E-cadherin不同,N-cadherin可促进肿瘤浸润转移。Twist, E-cadherin, N-cadherin都是EMT的重要分子。
基于上述考虑,本实验采用逆转录-聚合酶链反应(reverse transcription polymerase chain reaction, RT-PCR )、免疫组织化学技术对胃癌组织及其癌旁组织中Twist, E-cadherin,N-cadheri n的表达进行检测,为阐明胃癌的致病机制和防治提供实验基础和理论依据。
方法
1.采用RT-PCR方法检测58例人胃癌组织及58例相应癌旁组织中Twist, E-cadherin, N-cadherin mRNA的表达;
2.采用免疫组织化学方法检测58例人胃癌组织及癌旁组织中Twist, E-cadherin, N-cadherin蛋白表达;
3.采用SPSS 10.0统计软件进行统计学处理。采用t检验对计量资料进行统计学分析,采用x2检验对计数资料进行统计学分析,用相关进行相关分析,检验水准α=0.05.
结果
1.人胃癌组织RT-PCR方法检测结果显示: Twist, E-cadherin, N-cadherin分别于210bp、132bp、156bp处显带,为阳性表达。Twist, N-cadherin mRNA在胃癌组织中的阳性率分别为72.41%, 48.28%;明显高于癌旁组织的31.03%, 13.79%;E-cadherin mRNA在胃癌组织的阳性表达率为39.66%,明显低于癌旁组织的84.48%;差异有统计学意义(P<0.01)。
2.人胃癌组织免疫组织化学染色结果显示: Twist, N-cadherin蛋白在胃癌组织中的阳性表达率分别为75.9%,44.8%;明显高于癌旁组织的32.8% ,12.1% ;E-cadherin蛋白在胃癌组织中的阳性表达率为36.2%,明显低于癌旁组织的91.3%;差异有统计学意义(P<0.01)。
结论
1. Twist、N-cadherin mRNA及蛋白在胃癌中过表达,E-cadherin mRNA及蛋白在胃癌中低表达;可能与胃癌发生发展有关;
2. Twist, E-cadherin, N-cadherin与胃癌的浸润转移有关,三者共同参与了EMT过程。
3.联合检测三项指标对于进一步预测胃癌的转移、判断其预后具有重要意义。
Background and objective:
Twist was originally identified in Drosophila as a protein involved in the regulation of diverse developmental processes, particularly in the formation of mesoderm.The human Twist gene is located at chromosome 7p21.2.The Twist protein consists of 201 amino acids and its molecular weight is about 28kd.Twist protein is a transcription factor that belongs to the family of basic helix-loop-helix(bHLH)protein.The mechanism of bHLH molecules require that they either homo-or heterodimerize with other bHLH molecules,form a bipartite DNA-binding domain and bind to a conserved E-box region on the promoter of genes which activate or inhibit transcription.
Recent studies have shown that Twist is a potential oncogene and be involved in the protection of apoptosis via both p53-dependent and independent pathways.To date several studies revealed that Twist played crucial roles in tumorigenesis, invasion and metastasis,but its accurate molecular mechanisms remain unclear.However,there have been little available data on the role of Twist in the development and progession of gastric cancer;the molecule involved in the regulation of Twist and its mechanism was still unclear. We researched for the molecule involved in the regulation of Twist and its mechanisms.
Epithelial-mesenchymal transitions (EMT) is a process that epithelial cell layers lose polarity and acquire expression of mesenchymal components and manifest a migratory phenotype. It exists in many physiological and pathological p rocesses in human body. The progress of EMT involves a number of signal transduction pathways and complex molecular mechanisms, and is related to calcium catenin,growth factors, transcription factors, microenvironment, and so on. EMT play an important role in tumor metastasis. E-cadherin and N-cadherin are members of the family of transmembrane glycoproteins expressed on epithelial cells and are responsible for calciumdependent cell -to-celladhesion. E-cad can lead to Loss of cell adhesion,cell adhesion may contribute to loss of contact inhibition of growth, which is an early step in the neoplastic process.Furthermore, loss of cadherin activity may result in cancer cell detachment and metastasis.It has been suggested that, unlike E-cadherin, N-cadherin may promote invasion and metastasis of carcinoma. Twist,E- and N-cadherin are important molecules that modulate cell migration and tumor,invasion.
According to above metioned consider, in this study, Reverse transcription polymerase chain reaction (RT-PCR) technique and immunohistochemical method were used to detect the expression of Twist,E-cadherin and N-cadherin in gastric cancer. So that to provide experimental evidence for elucidating the etiopathogenesis, treatment and prevention in gastric cancer.
Methods:
1 .Reverse transcription polymerase chain reaction (RT- PCR) technique was used to examine the expressions of Twist,E-cadherin and N-cadherin mRNA in the 58 gastric cancer tissues and their 58 non-tumorous gastric tissues.
2. Supervision TM immunohistochemical method was used to detect the expression of Twist,E-cadherin and N-cadherin proteins in 58 cases of gastric cancer tissues and their non-tumorous gastric tissues.
3. SPSS 10.0 statistical software was applied to statistics the date. To categorical variable the sperman correlation analysis were used to analyze. To numerical variable the date was expressed with x士s and t test was used to compare these datas. The significant level was a =0.05.
Results:
1 .The positive expression of Twist,E-cadherin and N-cadherin locate in land 210bp,132bp,156bp. The positive expression of Twist,E-cadherin and N-cadherin mRNAs were 72.41%,39.66%, 48.28% in gastric cancer tissues, and were 31.03%, 84.48%, 13.79% in non-tumorous gastric tissue, respectively. (P<0.01).
2. The positive expression rates of Twist,E-cadherin and N-cadherin proteins were 75.9%,36.2%,44.8% in gastric cancer tissues, and were 32.8%,91.3%,12.1% in non-tumorous gastric tissue,respectively. (P<0.01).
Conclusions:
1 .The higher expressions of Twist,N-cadherin and the lower expression of E-cadherin in gastric cancer had the close relation to carcinogenesis of gastric cancer.
2. The expressions of Twist,E-cadherin and N-cadherin are related with the invasion,metastasis of gastric cancer,the genes of Twist,E-cadherin and N-cadherin participate with process of EMT together.
3.United measurement of the expression of Twist,E-cadherin and N-cadherin genes is helpful to predict metastasis of gastric cancer and to judge prognosis of gastric cancer.
引文
1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell, 2000, 100 (1):57-70.
2. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet. 2007. 8(5):341-52.
3. Yang J.Uu Y.Dissection of key events in tubular epithelial to myofibroblastt mmition and its implications in renal interstitialfibro sis. Am J Pathol,2001,159:1465-1475.
4.杨世忠,李晓武,董家鸿。上皮一间叶样表型转化参与肿瘤侵袭转移的分子机制研究进展。中华医学杂志.2005,185(46):3304- 3306.
5. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br JCancer.2006. 94(1): 13-7.
6. Sosic D, Richardson JA, Yu K, et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kap paB activity. Cell. 2003. 112(2): 169-80.
7. Bialek P, Kern B, Yang X, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell. 2004. 6(3): 423-35.
8. Pandolfi PP. Transcription therapy for cancer. Oncogene. 2001,20 (24):3116-27.
9. Kim JB, Islam S, Kim YG, et al. N-cadherin extracellular repeat 4mediates epithelial to mesenchymal transition and increased motility. J Cell Biol, 2000,151:1193-1205.
10. Thisse B, Met Messal M, Perrin-Sclunitt F. The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern.Nucleic Acids Res, 1987, 15: 3439-3453.
11. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.Cell,2004 ,117(7): 927-39.
12.王其,陈效平,关剑,等.Twist基因表达与肝癌多耐药细胞侵袭的相关性研究【J】.肝胆外科杂志,2006,14(1):66-68.
13. Erika Rosivatz, Ingrid Becker, Katja Specht, et al. Differential expre ssion of the Epithelial-Mesenchymal Transition Regulators Snail, SI Pl,and Twist in Gastric Cancer. Am J Pathol, 2002,161:1881-1891.
14. Maestro R, Dei 'fos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999,13;2207-2217.
15. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999, 13:2207-17.
16. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 1999, 13(17): 2207-2217.
17. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br JCancer.2006, 94(1): 13-7.
18. Berx, G. and Van Roy, F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and ma-lignant progression. Breast Cancer Res 2001,3:289-293.
19 Zazula M,Ferreira A M,Czopek JP,et al .CDH1 gene promoter hypermethylation in gastric cancer:relationship to Goseki grading
20. Noren NK, Liu BP, Burridge K, et al. p120 catenin regulates the Actin cytoskeleton via Rho family GTPases. J Cell Biol, 2000,150 (3):567-580.
21. Kin HC, Wheeler JM, Kim JC, et al. The E-cadherin gene(CDH1) Variants T304A and L599V in gastric and colorectal cancer patient in Korea. Gut,2000;47:262-267.
22. Machado JC, Carneiro FB. E-cadherin cxpression is correlated with the isolated cell/diffuse histotype and with features of biological aggressiveness of gastric carcinoma. Int J Surg Pathol,1998;6:135-144.
23. Machado JC, Soares P, Cameiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest, 1999;79:459-465.
24. Zhang CW, Xu WJ, Zhao ZS, et al. Clinical significance of E-cadhe rin expression in gastric cancer. Chin J Cancer,2000;19:57-60.
25. Handschuh GCandidus S, Luber B,et al. Tumour-associatedE-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene, 1999,18:4301 -4312.
26. Suzuki H, Itoh F, Toyota M, et al. Distinct methylation pattern and microsatellite instability in sporadic gasticcancer. Int J Cancer, 1999;83:309-313.
27. Melki JR, Vincent PC, Brown RD, et al. Hypermethylation of E-cadherin in leukemia. Melki Blood,2000;95:3208-3213.
28. Hiraguri S, Godfrey T, Nakamura H, et al. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Research, 1998;58:1972-1977.
29. Moersig W, Horn S, Hilker M, et al. Transfection of Ecadherin cDNA in human lung tumor cells reduces invasive potential of tumors [J]. Thorac Cardiovasc Surg, 2002,50(1):45-48.
30. Kim JB, Islam S, Kim YG, et al. N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol, 2000;151:1193一1205
31 . Hanza RB, Philips GR, Qiao RF, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion and metastasis [J]. J Cell Biol, 2000 21;148(4):779-790
32. Li C, Satyamoorthy K, and Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells [J]. Cancer Res, 2001 May 1;61(9):3819-3825
33. Tomita K, van Bokhoven A, van Leeders GJ, et al. Cadherin switching in human prostate cancer progression [J]. Cancer Res,2000 Jul 1 ;60(3):3650-3654
34. Li G,Satyamonrthy K,Herlyn M.N-cadherin-mediated intercellular Interactions promote survival and migration of melanoma cells[J]. Cancer Res,2001,61(9): 3819-3825.
35. Suyama K, Shapiro I, Guttma M, et al. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor [J].Cancer Cell, 2002,2(4):301-314.
36. Nieman MT, Prudoff RS, Johnson KR, et al. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression [J]. J Cell Biol, 1999,147 (3): 631-644.
37. Jaggi M, Nazemi T, Abrahams NA, et al. N-cadherin switching occurs in high Gleason grade prostate cancer [J]. Prostate, 2006,66(2):193-199.
38. Nagi C, Guttman M, Jaffer S, et al. N-cadherin expression in breast cancer: correlation with an aggressive histologic variantinvariantinvasive micropapillary carcinoma [J]. Breast Cancer Res Treat, 2005,94(3):225-235.
39. Makagiansar IT, Yusuf-Makagiansar H, Ikesue A, et al.N- cadherin involvement in the heterotypic adherence of malignant T-cells to epithelia[J].Mol Cell Biochem, 2002,233:1-8.
40. Rosivatz E, Becker I, Bamba M, et al. Neoexpression of N-cadherin in E-cadhern Positive Colon Cancers [J]. Int J Cancer, 2004,111(5):711-719.
41. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res,1994, 54:3929-33.
42. Oka H, Shiozaki H, Kobayashi K ,et al. Expression of E-cadherin cell adhesion molecules on human breast cancer tissues and its relationship to metastasis. Cancer Res ,1993, 53:1696 -701.
43. Pignatelli M, Ansari TW, and Gunter P. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol, 1994,174: 243-8.
44. Agnes M, Geraldine L, et al. Expression of E-, P-, N-cadherins and catenins on human bladder carcinoma cell lines. J Urol, 2000; 164(3 pt 1):826-35.
45. Popov Z, Gil-Diez de Medina S. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic infonnation. Br J Cancer ,2000, July, 83(2): 209-14.
46. Vernon AE,LaBonne C.Tumor Metastasis:A new twist on Epithelial-mesenchymal transition.Curr Biol.2004,14:719-721.
47. Thiery JP.Epithelial-mesenchymal transitions in tumor progression [J].Nat Rev Cancer,2002,2(6):442-454.
48. Foty RA,Steinberg MS.Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy.Int J Dev iol,2004,48 :397-409.
49. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004. 64(15): 5270-82.
50. Elias MC, Tozer KR, Silber JR, et al. TWIST is expressed in human gliomas and promotes invasion.Neoplasia.2005, 7(9): 824-37.
51. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat.(Basel), 1995, 154: 8-20
52. Thiery JP. Epithelial-mesenchymal transitions in tumour progressi on.Nat Rev Cancer, 2002, 2: 442-454.
53. Rosivatz E, Becker I, Specht K, et al. Differential exp ression of the epithelial mesenchymal transition regulators snail, SIP1, and twist in gastric cancer[ J ]. Am J Pathol, 2002, 161 (5): 1881-1891.
54. Martin TA,Goyal Watkins G,et a1.Expression of the transeription factors snail,slug,and twist and their clinical significance in human breast cancer[J].Ann Surg Omol,2005,12(6):488-9
55. Tran NL, Nagle RB, CressAE, et a l. N-cadherin exp ression in human prostate cancer carcinoma cell lines[ J ]. Am J Pathol , 1999,155: 787 - 798.
56. Liu, J., Shi, W., Warburton, D. A cysteine residue in the helix-loop- helix domain of Id2 is critical for homodimerization and function[J]. Biochem Biophys Res Commun, 2000, 273(3): 1042-1047.
57. Norton, J. D. ID helix-loop-helix proteins in cell growth, differentia tion and tumorigenesis[J]. J Cell Sci, 2000, 113(Pt 22): 3897-3905.
58. Rivera, R. R., Johns, C. P., Quan, J. et. Thymocyte selection is regul ated by the helix-loop-helix inhibitor protein, Id3[J].Immun,2000, 12(1): 17-26.
59. Yokota, Y, Mansouri, A., Mori, S.. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop helix inhibitor Id2[J]. Nature, 1999, 397(6721): 702-706.
60. Spicer, D. B., Rhee, J., Cheung, W. L.lynnetwwwdagriorglynnet. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist[J]. Science, 1996, 272(5267): 1476-1480.
61. Lee, M. S., Lowe, G. N., Strong, D. D.. TWIST, a basic helix-loop- helix transcription factor, can regulate the human osteogenic lineage[J]. J Cell Biochem, 1999, 75(4): 566-577.
62. Rice, D. P., Aberg, T., Chan. Integration of FGF and TWIST in calvarial bone and suture development[J]. Development, 2000,127 (9): 1845-1855.
63. Maestro, R., Dei Tos, A. P., Hamamori, Y .Twist is a potential oncogene that inhibits apoptosis[J]. Genes Dev, 1999,13(17):2207 -2217.
64. Valsesia-Wittmann, S., Magdeleine, M., Dupasquier, S.lynnetwwwdagriorglynnet. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells[J]. Cancer Cell, 2004, 6(6):625-630.
65. Kwok, W. K., Ling, M. T., Lee, T. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target[J].Cancer Res, 2005, 65(12): 5153-5162.
66. Kyo, S., Sakaguchi, J., Ohno, S. High Twist expression is involed in infiltrative endometrial cancer and affects patient survival[J]. Hum Pathol, 2006, 37(4): 431-438.
67. Kyo WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005, 65(12): 5153-62.
68. LARA D.M.DERYCKE and MARC E.BRACKE.N-cadherin in the spotlightof cell-cell adhesion,differentiation, embryogenesisinvasion and signaling[J].Int.J.Dev.Biol.48:463-476(2004).
69. Rosivatz E,Becker I,Bamba M,etal.Neoexpression of N-cadherin in E-cadherin positive colon cancers[J].Int J Cancer.2004 Sep 20;111(5):711-9.
70. Hazan RB,Phillips GR,Qiao RF,etal.Exogenous expression of N-cadherin in breast cancer cells induces cell migration,invasion,and metastasis[J].J Cell Biol2000;148:779–90.
71.刘云,刘志坚,陈江. E-cadherin、N-cadherin在大肠癌中的表达及其相关性研究[J].江西医学院学报,2006,46(5):29-32.
1. RobertL. The extracellularmatrix in development and regeneration[J]. Int J Dev Biol, 2004, 48(8) : 687-694.
2. Boyer B, Vall S, Edme N. Induction and regulation of epithelial mese nchymal transitions [J]. Biochem Pharmacol,2000,60(8):1091-1099.
3. Thiery J P. Epithelial-mesenchymal transitions in tumour progression [J]. CurrOp in Cell Biol, 2003, 15(6) : 740-746.
4. Yang J.Uu Y.Dissection of key events in tubular epithelial to myofi broblasttmmition and its implications in renal interstitialfibrosis.Am J Pathol,2001,159:1465-1475.
5.杨世忠,李晓武,董家鸿。上皮一间叶样表型转化参与肿瘤侵袭转移的分子机制研究进展。中华医学杂志.2005,185(46):3304-3306.
6. Gotzmann J. Hepatocytes convert to a fibroblastoid phenotype throu- gh the cooperation of TGF-beta1 and Ha-Ras: steps towards invasi-invasiveness[ J ]. Cell Sci, 2002, 115 (3) : 1189-1202.
7. Kang Y, Massague J. Epithelial-mesenchymal transitions:Twist in development and metastasis[J],Cell,2004,,118(3):277-279.
8. Lagamba D, Nawshad A, Hay ED. Microarray analysis of gene expr ession during epithelial-mesenchymal transformation. Dev Dyn. 200 5,234(1):132-142.
9. Radisky DC.Epithelial-mesenchymal transition.J Cell Sci.2005,118 :4325-26.
10. Cheng S,LoverDH.GelatinaseA(MMP-2)is necessary and subfieient for renal tubular cell epithelial-masenehymal transformation.Am J Pathol,2003,162:l937-1949.
11. Nangnku M.Chronic hypoxia and tubulointemtitial injury:A final common pathway to End-Stage Renal Failure.J Am Soc Nephrol.20 06.17:17-25.
12 Kalluri R ,Neilson EG. Epit helial mesenchymal transition and its implications for fibrosis[J ] . J Clin I nvest ,2003 ,112 :1776
13. Nieto MA. The snail superfamily of zinc-finger transcription factors [J ] . Nat Rev Mol Cell Biol,2002,155-166.
14. Bolos V , Peinado H , Perez-Moreno MA. The transcription factor Slug represses E-cadherin expression and induces epitjelial-to-mesen chymal transitions : a comparison wit h Snail and E47 repressors [J] .J Cell Sci , 2003 ,499-511.
15. Hajra KM , Chen DY, Fearon ER. The SLU Gzinc-finger protein represses E-cadherin in breast cancer [ J ] . Cancer Res , 2002,1613 -1618.
16. Edme N , Downward J , Thiery J P , et al . Ras induces NBT-II epit- helial cell scattering through t he coordinate activities of Rac and MAPK pat hways [J ] . J Cell Sci , 2002 , 2591 - 2601.
17. Moinfar F , Man YG, Arnould L , et al . Concurrent and indipend ent genetic alterations in t he st romal and epit helial cells of mamm ary carcinoma : implications for tumorigenesis [J ] . Cancer Res , 2 000 , 2562 - 2566.
18. Korsching E,Packeisen J,Liedtke C,et a1.The origin of vimentin expression in invasive breast cancer:epithelial-mesenchymal transiti on,myoepithelial histogenesis or histogenesis from progenitor cells with bilinear diferentiation potential[J].Patho1.2005,206(4):451 -457.
19. Kurrey NK,K A,Bapat SA.Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level[J].Gynecol Oncol,2005,97(1):155-165.
20. Fischer AN,Herrera B,MikulaM,et at.Integration of Ras sub effector signaling in TGF-beta mediated late stage hepatic carcinom a[J]. Carcinogenesis,2005,26(5):931-942.
21. Nakajima S,Doi R,Toyoda E,Tsuji S,et a1.N-cadherln expressionand epithelial-mesenchymal transition in pan creatic carcinoma[J]. Clin Cancer Res.2004,10(12 Pt 1):4125-4133.
22. Sass PM. The involvement of selectins in cell adhesion, tumor progression, and metastasis. Cancer Investigation,1998, 16:322.
23. Syrigos KN,Harrington KJ and Pignatelli M. Role of adhesion mol ecules in bladder cancer: an important part of the jigsaw. Urology, 1999, 53:428.
24. Vleminckx K, Vakaet L, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 1991,66(12): 107-19.
25. Agnes M, Geraldine L et al .Expression of E-, P-, N-cadherins and catenins on human bladder carcinoma cell lines. J Urol 2000; 164(3 pt I):826-35
26. Li Z, Gallin WJ, Lauzon G and Pasdar M. L-CAM expression induces fibroblast-epidermoid transition in squamous carcinoma cells and down-regulates the endogenous N-cadherin. J Cell Sci 1998; 111:1005-19.
27. Shimoyama Y, Hirohashi S et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res1989; 49: 2128-33.
28. Matsuyoshi N. and Imamura S. Multiple cadherms are expressed inhuman fibroblasts. Biochem Biophys Res Comm 1997; 235(2):355-358.
29. Li Z, Gallin WJ, Lauzon G and Pasdar M. L-CAM expression induces fibroblast-epidermoid transition in squamous carcinoma cells and down-regulates the endogenous N-cadherin. J Cell Sci 1998; 111:1005-19.
30. Islam S, Carey TE, Wolf GT, Wheelock MJ and Johnson KR. Expression of N-eadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996; 135:1643-54.
31. Hazan RB, Kang L, Whooley BP and Borgen Pl. N-cadherin promoters adhesion between invasive breast cancer cells and the stroma. Cell Adhes Comin 1997, 4:399 -411.
32. Shapiro L, Fannon AM, Kwong PD, et al. Structual basis of cell-cell adhesion by cadherins. Nature, 1995, 374(4):327-36.
33. Bindels E, VermeyM, Beemd R, et al. E-cadherin promoter intraepithelial expansion of bladder carcinoma cell in an vitro model of carcinoma in situ. Cancer Res, 2000, 60(1):177-81.
34. Mueller S, Cadenas E, Schonthal AH. P21 WAF 1 regulates anchorage in dependent growth of HCTI 16 colon carcinoma cells via E-cadherin expression. Cancer Res, 2000,60(l):156-63.
35. Jiang WG. E-cadherin and its associated protein, cancer invasionand metastasis. Br J Surgery, 1996, 83(3):437-46.
36. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999, 24:73-6.
37. Graziano F, Humar B, Guilford P The role of the E-cadherin gene (CDH 1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 2003, 14:1705-13.
38. Heimann R, Lan F, Mcbride R, et al. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res, 2000, 60(2):298-304.
39. Berx, G. and Van Roy, F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and ma-lignant progression. Breast Cancer Res 2001,3:289-293.
40 Zazula M,Ferreira A M,Czopek JP,et al .CDH1 gene promoter hypermethylation in gastric cancer:relationship to Goseki grading microsatellite instability status,and EBV invasion[J].Diagn Mol Pathol,2006;15(1):24-9
41. Vleminckx K, Vakaet L, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 1991,66(12): 107-19.
43. Jiang WG. E-cadherin and its associated protein, cancer invasion and metastasis. Br J Surgery, 1996, 83(3):437-46.
42. Mareel M, Van Roy F. The human E-cadherin /catenin complex: a potent invasion and tumor suppressor. Verh K Acad Genesskd Belg, 1998, 60(6):567-598.
44. Soler AP, Knudsen KA, Tecson-Miguel A, et al. Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer, 2001,1[J]:16-23.
45. Chalmers 1J, Hofler H, Atkinson MJ. Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma. Genomics. 1999, 57(1):160-3.
46. Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphi sm in the E-cadherin gene promoter alters transcriptional activities. Cancer Res, 2000, 60:873-6.
47. Ribeiro-Filho LA, Franks J, Sasaki M, et al. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog, 2002, 34(4):187-98.
48. Murant SJ, Rolley N, Phillips SM, et al. Allelic imbalance within the E-cadherin gene is an infrequent event in prostate carcinogenesis. Genes Chromosomes Cancel, 2000,27(l):104-9.
49. Pharoah PD, Oliveira C, Machado JC, et al. CDHI c-160a promotor polymorphism is not associated with risk of stomach cancer. Int J Cancer, 2002, 10;101(2):196-7.
50 Wu MS, Huang SP, Chang YT, et al. Association of the一160 C一a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer, 2002, 94(5):1443-8.
51. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res,1994, 54:3929-33.
52. Oka H, Shiozaki H, Kobayashi K ,et al. Expression of E-cadherin cell adhesion molecules on human breast cancer tissues and its relationship to metastasis. Cancer Res ,1993, 53:1696 -701.
53. Pignatelli M, Ansari TW, and Gunter P. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol, 1994,174: 243-8.
54. Stone J. Bevan S, Cunningham D, et al. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer, 1999,79:1935-7.
55. Agnes M, Geraldine L, et al. Expression of E-, P-, N-cadherins and catenins on human bladder carcinoma cell lines. J Urol, 2000; 164(3 pt 1):826-35.
56. Shariat SF, Pahlavan S ,et al. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology, 2001,57 (1):60-5.
57. Byrne RR, Shariat SF, et al. E-cadherin inmunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow up. J Urol, 2001,165(5):1473-9
58. Byme RR, Chakraborty S. Brown R et al. An immunohistochemical study of E-cadherin in transitional cell carcinoma and carcinoma in situ in frozen and paraffin sections. J Urol ,1996,155(suppl): 614A.
59. Frixen UH, Behrens J, Sachs M et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol ,1991,113:173-85.
60.李龙承,张旭,陈忠等.E一钙粘连素基因启动子甲基化与该基因表达及前列腺癌病理分级的关系.中华实验外科杂志,2000,17(5): 431-2.
61. Sun W ,Herrera GA. E-cadherin expression in urothelial carcinoma in superficial papillary transitional cell carcinoma, and invasive transitional carcinoma. Hum Pathol, 2002, Oct, 33(10): 996-1000.
62. Rao J, Seligson D, Visapaa H, et al. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer, 2002, Sep 15, 95(6): 1247-57.
63. Popov Z, Gil-Diez de Medina S. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic infonnation. Br J Cancer ,2000, July, 83(2): 209-14.
64. Byrne RR, Shariat SF, et al. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow up.J Urol, 2001,165(5): 1473-9.
65. Wakatsuki S, watanabe R, et al. Loss of human E-cadherin correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter in urinary bladder. Cancer, 1996, 103:Il-17.
66. Mialhe A, Louis J. Expression of E-cadherin and a-,β-andγ-catenin in human bladder carcinomas: are they good prognostic factors? Invasion Metastasis ,1997, 17:124-37.
67. Li LC, Chui RM, Sasaki M ,et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Research ,2000,60:873-6.
68. Batsche E,Cremisi C .Opposite transcriptional activity between the wild type c-myc gene coding for c-mycland c-myc proteins and c-myc2 separately. Oncogene ,1999,18:5662-5671.
69. Bauer A,Chauvet S,Huber O, et al. Pontin52 and Reptin52 function as antagonistic regulators of p-catenin signaling activity. EMBO J, 2000,19:6121-6130.
70. Battle E,Sancho E,Franci C, et al. The transcription factor Snail is a repressor of e-cadherin gene expression in epithelial tumor cells. Nat Cell Boil, 2000,2:84-89.
71. Cano A,Prtrz-moreno MA,Rodrigo I, et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repression E-cadherin expression. Nat Cell Boil, 2000,2:76-83.
72. Huang GT, Lee HS, Chen CH .Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepatogastroenterolo- gy. 1999,46: 1923-1927.
73. Huber AH,Stewart DB,Laurents DV et al. The cadherin cytoplasmic domain is unstructured in the absence of p-catenin. A possible mechanism for regulating cadherin turnover. J BoilChem. 2001,276 :12301-12309.
74. Noe VFingleton B,Jacobs K et al. Release of an invasion promotor E-cadherin fragment by matrilysin and stromelysin-1 .J Cell Sci 2001,114:111-118.
75. Menke A, Philippi C, Vogelmann R, et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res, 2001, 61:3508-3517.
76.黄菊,程夏楷,杨彬,等.E一钙黏蛋白复合体及其对肿瘤细胞的作用[J].Chemistry of ,2005,25(3):247-250.
77. Foty RA,Steinberg MS.Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy.Int J Dev iol,2004,48 :397-409.
78. Thiery JP.Epithelial-mesenchymal transitions in tumor progression[J].Nat Rev Cancer,2002,2(6):442-454.
79. Li G,Satyamonrthy K,Herlyn M.N-cadherin-mediated intercellular Interactions promote survival and migration of melanoma cells[J]. Cancer Res,2001,61(9): 3819-3825.
80. Thisse B, Met Messal M, Perrin-Sclunitt F. The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern.Nucleic Acids Res, 1987, 15: 3439-3453.
81. Desprez PY, Sumida T, Coppe JP. Helix-loop-helix proteins in mammary gland development and breast cancer.J Mammary Gland Biol Neoplasia, 2003, 8:225-9.
82. Castanon 1, Baylies MK. A Twist in fate: evolutionary comparison of Twist structure and function. Gene, 2002, 287: 11-22.
83. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, et al. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell. 2004, 6(6): 625-30.
84. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999, 13:2207-17.
85. KwokW K, LingM T, Lee TW, et al. Up-regulation of TW IST in prostate cancer and its imp lication as a therapeutic target [ J ].Cancer Res, 2005, 65 (12) : 5153-5162.
86. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 1999, 13(17): 2207-2217.
87. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br JCancer.2006, 94(1): 13-7.
88. Stasiopoulos IA, Mironchik Y, Raman A, et al. HOXA52twist inter action alters p53 homeostasis in breast cancer cells [ J ]. J Biol Che m, 2005, 280 (3) : 2294-2299.
89. Hamamori Y, SartorelliV, Ogrysko V, et al. Regulation of histone acetyltransferases p300 and PCAF by the bHLH p rotein twist and adenoviral oncop rotein E1A [ J ]. Cell, 1999, 96 (3) : 405-413.
90. Sosic D, Richardson JA, Yu K, et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell. 2003, 112(2): 169-80.
91. Hjiantoniou E, Iseki S, Uney JB, et al. DNazyme-mediated cleavage of Twist transcripts and increase in cellular apoptosis. Biochem Biophys Res Commam. 2003, 300(1): 178-81.
92. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004, 64(15): 5270-82.
93. Rosivatz E, Becker L, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002, 161(5): 1881-91.
94. Watanabe O, Imamura H, Shimizu T, et al. Expression of twist and writ in human breast cancer.Anticancer Res. 2004, 24(6): 3851-6.
95. Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005, 65(12): 5153-62.
96. Martin TA, Goyal A, Watkins G, et al. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 2005, 12(6): 488-96.
97. Sosic D, Richardson JA, Yu K, et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell, 2003, 112(2): 169-80.
98. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell,2004,117(7): 927-39.
99. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004. 64(15): 5270-82.
100. Erika Rosivatz, Ingrid Becker, Katja Specht, et al. Differential expression of the Epithelial-Mesenchymal Transition Regulators Snail, SIPl,and Twist in Gastric Cancer. Am J Pathol, 2002,161:1881-1891.
101. Bialek P, Kern B, Yang X, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell. 2004, 6(3): 423-35.
102. Tamura M, Noda M. Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. J Cell Biochem. 1999, 72(2): 167-76.
103. Villavicencio EH, Yoon JW, Frank DJ, et al. Cooperative E-box regulation of human GLII by TWIST and USF. Genesis, 2002, 32: 247-58.
104. Maestro R, Dei 'fos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999,13;2207-2217.
105.王其,陈效平,关剑,等.Twist基因表达与肝癌多耐药细胞侵袭的相关性研究【J】.肝胆外科杂志,2006,14(1):66-68.
106. Wang X, Ling MT, Guan XY, et al. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene, 2004, 23: 474-82.
107. Puisieux A, Valsesia2Wittmann S, Ansieau S, et al. A twist for survival and cancer p rogression[J]. Br J Cancer, 2006, 94 ( 1 ) :13217.
108. Elias MC, Tozer KR, Silber JR, et al. TWIST is expressed in human gliomas and promotes invasion.Neoplasia.2005, 7(9): 824-37.
109. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat.(Basel), 1995, 154: 8-20
110. Thiery JP. Epithelial-mesenchymal transitions in tumour progressi on.Nat Rev Cancer, 2002, 2: 442-454.
111. Rosivatz E, Becker I, Specht K, et al. Differential exp ression of the epithelial mesenchymal transition regulators snail, SIP1, and twist in gastric cancer[ J ]. Am J Pathol, 2002, 161 (5): 1881-18 91.
112. Castanon I, BayliesM K. A Twist in fate: evolutionary comparison of Twist structure and function [ J ]. Gene, 2002, 287 ( 122 ) :11- 22.
113. Sosic D, Richardson J A, Yu K, et al. Twist regulate cytokine gene expression through a negative feedback loop that rep resses NF-κB activity[ J ]. Cell, 2003, 112 (2) : 169-180.
114. Karreth F,Tuveson DA.Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis[J].Cancer Biol Ther,2004,3(11):1058-1059.
115. Watanabe O,Imamura H,Shimizu T,et a1.Expression of twist andwnt in human breast cancer[J].Anticancer Res,2004,24(6):3851- 3856.
116. Vernon AE,LaBonne C.Tumor Metastasis:A new twist on Epithelial-mesenchymal transition.Curr Biol.2004,14:719-721.
117. Martin TA,Goyal Watkins G,et a1.Expression of the transeription factors snail,slug,and twist and their clinical significance in human breast cancer[J].Ann Surg Omol,2005,12(6):488-96.
2. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet. 2007. 8(5):341-52.
3. Yang J.Uu Y.Dissection of key events in tubular epithelial to myofibroblastt mmition and its implications in renal interstitialfibro sis. Am J Pathol,2001,159:1465-1475.
4.杨世忠,李晓武,董家鸿。上皮一间叶样表型转化参与肿瘤侵袭转移的分子机制研究进展。中华医学杂志.2005,185(46):3304- 3306.
5. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br JCancer.2006. 94(1): 13-7.
6. Sosic D, Richardson JA, Yu K, et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kap paB activity. Cell. 2003. 112(2): 169-80.
7. Bialek P, Kern B, Yang X, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell. 2004. 6(3): 423-35.
8. Pandolfi PP. Transcription therapy for cancer. Oncogene. 2001,20 (24):3116-27.
9. Kim JB, Islam S, Kim YG, et al. N-cadherin extracellular repeat 4mediates epithelial to mesenchymal transition and increased motility. J Cell Biol, 2000,151:1193-1205.
10. Thisse B, Met Messal M, Perrin-Sclunitt F. The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern.Nucleic Acids Res, 1987, 15: 3439-3453.
11. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.Cell,2004 ,117(7): 927-39.
12.王其,陈效平,关剑,等.Twist基因表达与肝癌多耐药细胞侵袭的相关性研究【J】.肝胆外科杂志,2006,14(1):66-68.
13. Erika Rosivatz, Ingrid Becker, Katja Specht, et al. Differential expre ssion of the Epithelial-Mesenchymal Transition Regulators Snail, SI Pl,and Twist in Gastric Cancer. Am J Pathol, 2002,161:1881-1891.
14. Maestro R, Dei 'fos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999,13;2207-2217.
15. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999, 13:2207-17.
16. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 1999, 13(17): 2207-2217.
17. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br JCancer.2006, 94(1): 13-7.
18. Berx, G. and Van Roy, F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and ma-lignant progression. Breast Cancer Res 2001,3:289-293.
19 Zazula M,Ferreira A M,Czopek JP,et al .CDH1 gene promoter hypermethylation in gastric cancer:relationship to Goseki grading
20. Noren NK, Liu BP, Burridge K, et al. p120 catenin regulates the Actin cytoskeleton via Rho family GTPases. J Cell Biol, 2000,150 (3):567-580.
21. Kin HC, Wheeler JM, Kim JC, et al. The E-cadherin gene(CDH1) Variants T304A and L599V in gastric and colorectal cancer patient in Korea. Gut,2000;47:262-267.
22. Machado JC, Carneiro FB. E-cadherin cxpression is correlated with the isolated cell/diffuse histotype and with features of biological aggressiveness of gastric carcinoma. Int J Surg Pathol,1998;6:135-144.
23. Machado JC, Soares P, Cameiro F, et al. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest, 1999;79:459-465.
24. Zhang CW, Xu WJ, Zhao ZS, et al. Clinical significance of E-cadhe rin expression in gastric cancer. Chin J Cancer,2000;19:57-60.
25. Handschuh GCandidus S, Luber B,et al. Tumour-associatedE-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene, 1999,18:4301 -4312.
26. Suzuki H, Itoh F, Toyota M, et al. Distinct methylation pattern and microsatellite instability in sporadic gasticcancer. Int J Cancer, 1999;83:309-313.
27. Melki JR, Vincent PC, Brown RD, et al. Hypermethylation of E-cadherin in leukemia. Melki Blood,2000;95:3208-3213.
28. Hiraguri S, Godfrey T, Nakamura H, et al. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Research, 1998;58:1972-1977.
29. Moersig W, Horn S, Hilker M, et al. Transfection of Ecadherin cDNA in human lung tumor cells reduces invasive potential of tumors [J]. Thorac Cardiovasc Surg, 2002,50(1):45-48.
30. Kim JB, Islam S, Kim YG, et al. N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol, 2000;151:1193一1205
31 . Hanza RB, Philips GR, Qiao RF, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion and metastasis [J]. J Cell Biol, 2000 21;148(4):779-790
32. Li C, Satyamoorthy K, and Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells [J]. Cancer Res, 2001 May 1;61(9):3819-3825
33. Tomita K, van Bokhoven A, van Leeders GJ, et al. Cadherin switching in human prostate cancer progression [J]. Cancer Res,2000 Jul 1 ;60(3):3650-3654
34. Li G,Satyamonrthy K,Herlyn M.N-cadherin-mediated intercellular Interactions promote survival and migration of melanoma cells[J]. Cancer Res,2001,61(9): 3819-3825.
35. Suyama K, Shapiro I, Guttma M, et al. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor [J].Cancer Cell, 2002,2(4):301-314.
36. Nieman MT, Prudoff RS, Johnson KR, et al. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression [J]. J Cell Biol, 1999,147 (3): 631-644.
37. Jaggi M, Nazemi T, Abrahams NA, et al. N-cadherin switching occurs in high Gleason grade prostate cancer [J]. Prostate, 2006,66(2):193-199.
38. Nagi C, Guttman M, Jaffer S, et al. N-cadherin expression in breast cancer: correlation with an aggressive histologic variantinvariantinvasive micropapillary carcinoma [J]. Breast Cancer Res Treat, 2005,94(3):225-235.
39. Makagiansar IT, Yusuf-Makagiansar H, Ikesue A, et al.N- cadherin involvement in the heterotypic adherence of malignant T-cells to epithelia[J].Mol Cell Biochem, 2002,233:1-8.
40. Rosivatz E, Becker I, Bamba M, et al. Neoexpression of N-cadherin in E-cadhern Positive Colon Cancers [J]. Int J Cancer, 2004,111(5):711-719.
41. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res,1994, 54:3929-33.
42. Oka H, Shiozaki H, Kobayashi K ,et al. Expression of E-cadherin cell adhesion molecules on human breast cancer tissues and its relationship to metastasis. Cancer Res ,1993, 53:1696 -701.
43. Pignatelli M, Ansari TW, and Gunter P. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol, 1994,174: 243-8.
44. Agnes M, Geraldine L, et al. Expression of E-, P-, N-cadherins and catenins on human bladder carcinoma cell lines. J Urol, 2000; 164(3 pt 1):826-35.
45. Popov Z, Gil-Diez de Medina S. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic infonnation. Br J Cancer ,2000, July, 83(2): 209-14.
46. Vernon AE,LaBonne C.Tumor Metastasis:A new twist on Epithelial-mesenchymal transition.Curr Biol.2004,14:719-721.
47. Thiery JP.Epithelial-mesenchymal transitions in tumor progression [J].Nat Rev Cancer,2002,2(6):442-454.
48. Foty RA,Steinberg MS.Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy.Int J Dev iol,2004,48 :397-409.
49. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004. 64(15): 5270-82.
50. Elias MC, Tozer KR, Silber JR, et al. TWIST is expressed in human gliomas and promotes invasion.Neoplasia.2005, 7(9): 824-37.
51. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat.(Basel), 1995, 154: 8-20
52. Thiery JP. Epithelial-mesenchymal transitions in tumour progressi on.Nat Rev Cancer, 2002, 2: 442-454.
53. Rosivatz E, Becker I, Specht K, et al. Differential exp ression of the epithelial mesenchymal transition regulators snail, SIP1, and twist in gastric cancer[ J ]. Am J Pathol, 2002, 161 (5): 1881-1891.
54. Martin TA,Goyal Watkins G,et a1.Expression of the transeription factors snail,slug,and twist and their clinical significance in human breast cancer[J].Ann Surg Omol,2005,12(6):488-9
55. Tran NL, Nagle RB, CressAE, et a l. N-cadherin exp ression in human prostate cancer carcinoma cell lines[ J ]. Am J Pathol , 1999,155: 787 - 798.
56. Liu, J., Shi, W., Warburton, D. A cysteine residue in the helix-loop- helix domain of Id2 is critical for homodimerization and function[J]. Biochem Biophys Res Commun, 2000, 273(3): 1042-1047.
57. Norton, J. D. ID helix-loop-helix proteins in cell growth, differentia tion and tumorigenesis[J]. J Cell Sci, 2000, 113(Pt 22): 3897-3905.
58. Rivera, R. R., Johns, C. P., Quan, J. et. Thymocyte selection is regul ated by the helix-loop-helix inhibitor protein, Id3[J].Immun,2000, 12(1): 17-26.
59. Yokota, Y, Mansouri, A., Mori, S.. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop helix inhibitor Id2[J]. Nature, 1999, 397(6721): 702-706.
60. Spicer, D. B., Rhee, J., Cheung, W. L.lynnetwwwdagriorglynnet. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist[J]. Science, 1996, 272(5267): 1476-1480.
61. Lee, M. S., Lowe, G. N., Strong, D. D.. TWIST, a basic helix-loop- helix transcription factor, can regulate the human osteogenic lineage[J]. J Cell Biochem, 1999, 75(4): 566-577.
62. Rice, D. P., Aberg, T., Chan. Integration of FGF and TWIST in calvarial bone and suture development[J]. Development, 2000,127 (9): 1845-1855.
63. Maestro, R., Dei Tos, A. P., Hamamori, Y .Twist is a potential oncogene that inhibits apoptosis[J]. Genes Dev, 1999,13(17):2207 -2217.
64. Valsesia-Wittmann, S., Magdeleine, M., Dupasquier, S.lynnetwwwdagriorglynnet. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells[J]. Cancer Cell, 2004, 6(6):625-630.
65. Kwok, W. K., Ling, M. T., Lee, T. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target[J].Cancer Res, 2005, 65(12): 5153-5162.
66. Kyo, S., Sakaguchi, J., Ohno, S. High Twist expression is involed in infiltrative endometrial cancer and affects patient survival[J]. Hum Pathol, 2006, 37(4): 431-438.
67. Kyo WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005, 65(12): 5153-62.
68. LARA D.M.DERYCKE and MARC E.BRACKE.N-cadherin in the spotlightof cell-cell adhesion,differentiation, embryogenesisinvasion and signaling[J].Int.J.Dev.Biol.48:463-476(2004).
69. Rosivatz E,Becker I,Bamba M,etal.Neoexpression of N-cadherin in E-cadherin positive colon cancers[J].Int J Cancer.2004 Sep 20;111(5):711-9.
70. Hazan RB,Phillips GR,Qiao RF,etal.Exogenous expression of N-cadherin in breast cancer cells induces cell migration,invasion,and metastasis[J].J Cell Biol2000;148:779–90.
71.刘云,刘志坚,陈江. E-cadherin、N-cadherin在大肠癌中的表达及其相关性研究[J].江西医学院学报,2006,46(5):29-32.
1. RobertL. The extracellularmatrix in development and regeneration[J]. Int J Dev Biol, 2004, 48(8) : 687-694.
2. Boyer B, Vall S, Edme N. Induction and regulation of epithelial mese nchymal transitions [J]. Biochem Pharmacol,2000,60(8):1091-1099.
3. Thiery J P. Epithelial-mesenchymal transitions in tumour progression [J]. CurrOp in Cell Biol, 2003, 15(6) : 740-746.
4. Yang J.Uu Y.Dissection of key events in tubular epithelial to myofi broblasttmmition and its implications in renal interstitialfibrosis.Am J Pathol,2001,159:1465-1475.
5.杨世忠,李晓武,董家鸿。上皮一间叶样表型转化参与肿瘤侵袭转移的分子机制研究进展。中华医学杂志.2005,185(46):3304-3306.
6. Gotzmann J. Hepatocytes convert to a fibroblastoid phenotype throu- gh the cooperation of TGF-beta1 and Ha-Ras: steps towards invasi-invasiveness[ J ]. Cell Sci, 2002, 115 (3) : 1189-1202.
7. Kang Y, Massague J. Epithelial-mesenchymal transitions:Twist in development and metastasis[J],Cell,2004,,118(3):277-279.
8. Lagamba D, Nawshad A, Hay ED. Microarray analysis of gene expr ession during epithelial-mesenchymal transformation. Dev Dyn. 200 5,234(1):132-142.
9. Radisky DC.Epithelial-mesenchymal transition.J Cell Sci.2005,118 :4325-26.
10. Cheng S,LoverDH.GelatinaseA(MMP-2)is necessary and subfieient for renal tubular cell epithelial-masenehymal transformation.Am J Pathol,2003,162:l937-1949.
11. Nangnku M.Chronic hypoxia and tubulointemtitial injury:A final common pathway to End-Stage Renal Failure.J Am Soc Nephrol.20 06.17:17-25.
12 Kalluri R ,Neilson EG. Epit helial mesenchymal transition and its implications for fibrosis[J ] . J Clin I nvest ,2003 ,112 :1776
13. Nieto MA. The snail superfamily of zinc-finger transcription factors [J ] . Nat Rev Mol Cell Biol,2002,155-166.
14. Bolos V , Peinado H , Perez-Moreno MA. The transcription factor Slug represses E-cadherin expression and induces epitjelial-to-mesen chymal transitions : a comparison wit h Snail and E47 repressors [J] .J Cell Sci , 2003 ,499-511.
15. Hajra KM , Chen DY, Fearon ER. The SLU Gzinc-finger protein represses E-cadherin in breast cancer [ J ] . Cancer Res , 2002,1613 -1618.
16. Edme N , Downward J , Thiery J P , et al . Ras induces NBT-II epit- helial cell scattering through t he coordinate activities of Rac and MAPK pat hways [J ] . J Cell Sci , 2002 , 2591 - 2601.
17. Moinfar F , Man YG, Arnould L , et al . Concurrent and indipend ent genetic alterations in t he st romal and epit helial cells of mamm ary carcinoma : implications for tumorigenesis [J ] . Cancer Res , 2 000 , 2562 - 2566.
18. Korsching E,Packeisen J,Liedtke C,et a1.The origin of vimentin expression in invasive breast cancer:epithelial-mesenchymal transiti on,myoepithelial histogenesis or histogenesis from progenitor cells with bilinear diferentiation potential[J].Patho1.2005,206(4):451 -457.
19. Kurrey NK,K A,Bapat SA.Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level[J].Gynecol Oncol,2005,97(1):155-165.
20. Fischer AN,Herrera B,MikulaM,et at.Integration of Ras sub effector signaling in TGF-beta mediated late stage hepatic carcinom a[J]. Carcinogenesis,2005,26(5):931-942.
21. Nakajima S,Doi R,Toyoda E,Tsuji S,et a1.N-cadherln expressionand epithelial-mesenchymal transition in pan creatic carcinoma[J]. Clin Cancer Res.2004,10(12 Pt 1):4125-4133.
22. Sass PM. The involvement of selectins in cell adhesion, tumor progression, and metastasis. Cancer Investigation,1998, 16:322.
23. Syrigos KN,Harrington KJ and Pignatelli M. Role of adhesion mol ecules in bladder cancer: an important part of the jigsaw. Urology, 1999, 53:428.
24. Vleminckx K, Vakaet L, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 1991,66(12): 107-19.
25. Agnes M, Geraldine L et al .Expression of E-, P-, N-cadherins and catenins on human bladder carcinoma cell lines. J Urol 2000; 164(3 pt I):826-35
26. Li Z, Gallin WJ, Lauzon G and Pasdar M. L-CAM expression induces fibroblast-epidermoid transition in squamous carcinoma cells and down-regulates the endogenous N-cadherin. J Cell Sci 1998; 111:1005-19.
27. Shimoyama Y, Hirohashi S et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res1989; 49: 2128-33.
28. Matsuyoshi N. and Imamura S. Multiple cadherms are expressed inhuman fibroblasts. Biochem Biophys Res Comm 1997; 235(2):355-358.
29. Li Z, Gallin WJ, Lauzon G and Pasdar M. L-CAM expression induces fibroblast-epidermoid transition in squamous carcinoma cells and down-regulates the endogenous N-cadherin. J Cell Sci 1998; 111:1005-19.
30. Islam S, Carey TE, Wolf GT, Wheelock MJ and Johnson KR. Expression of N-eadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996; 135:1643-54.
31. Hazan RB, Kang L, Whooley BP and Borgen Pl. N-cadherin promoters adhesion between invasive breast cancer cells and the stroma. Cell Adhes Comin 1997, 4:399 -411.
32. Shapiro L, Fannon AM, Kwong PD, et al. Structual basis of cell-cell adhesion by cadherins. Nature, 1995, 374(4):327-36.
33. Bindels E, VermeyM, Beemd R, et al. E-cadherin promoter intraepithelial expansion of bladder carcinoma cell in an vitro model of carcinoma in situ. Cancer Res, 2000, 60(1):177-81.
34. Mueller S, Cadenas E, Schonthal AH. P21 WAF 1 regulates anchorage in dependent growth of HCTI 16 colon carcinoma cells via E-cadherin expression. Cancer Res, 2000,60(l):156-63.
35. Jiang WG. E-cadherin and its associated protein, cancer invasionand metastasis. Br J Surgery, 1996, 83(3):437-46.
36. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999, 24:73-6.
37. Graziano F, Humar B, Guilford P The role of the E-cadherin gene (CDH 1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 2003, 14:1705-13.
38. Heimann R, Lan F, Mcbride R, et al. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res, 2000, 60(2):298-304.
39. Berx, G. and Van Roy, F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and ma-lignant progression. Breast Cancer Res 2001,3:289-293.
40 Zazula M,Ferreira A M,Czopek JP,et al .CDH1 gene promoter hypermethylation in gastric cancer:relationship to Goseki grading microsatellite instability status,and EBV invasion[J].Diagn Mol Pathol,2006;15(1):24-9
41. Vleminckx K, Vakaet L, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 1991,66(12): 107-19.
43. Jiang WG. E-cadherin and its associated protein, cancer invasion and metastasis. Br J Surgery, 1996, 83(3):437-46.
42. Mareel M, Van Roy F. The human E-cadherin /catenin complex: a potent invasion and tumor suppressor. Verh K Acad Genesskd Belg, 1998, 60(6):567-598.
44. Soler AP, Knudsen KA, Tecson-Miguel A, et al. Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer, 2001,1[J]:16-23.
45. Chalmers 1J, Hofler H, Atkinson MJ. Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma. Genomics. 1999, 57(1):160-3.
46. Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphi sm in the E-cadherin gene promoter alters transcriptional activities. Cancer Res, 2000, 60:873-6.
47. Ribeiro-Filho LA, Franks J, Sasaki M, et al. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog, 2002, 34(4):187-98.
48. Murant SJ, Rolley N, Phillips SM, et al. Allelic imbalance within the E-cadherin gene is an infrequent event in prostate carcinogenesis. Genes Chromosomes Cancel, 2000,27(l):104-9.
49. Pharoah PD, Oliveira C, Machado JC, et al. CDHI c-160a promotor polymorphism is not associated with risk of stomach cancer. Int J Cancer, 2002, 10;101(2):196-7.
50 Wu MS, Huang SP, Chang YT, et al. Association of the一160 C一a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer, 2002, 94(5):1443-8.
51. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res,1994, 54:3929-33.
52. Oka H, Shiozaki H, Kobayashi K ,et al. Expression of E-cadherin cell adhesion molecules on human breast cancer tissues and its relationship to metastasis. Cancer Res ,1993, 53:1696 -701.
53. Pignatelli M, Ansari TW, and Gunter P. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol, 1994,174: 243-8.
54. Stone J. Bevan S, Cunningham D, et al. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer, 1999,79:1935-7.
55. Agnes M, Geraldine L, et al. Expression of E-, P-, N-cadherins and catenins on human bladder carcinoma cell lines. J Urol, 2000; 164(3 pt 1):826-35.
56. Shariat SF, Pahlavan S ,et al. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology, 2001,57 (1):60-5.
57. Byrne RR, Shariat SF, et al. E-cadherin inmunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow up. J Urol, 2001,165(5):1473-9
58. Byme RR, Chakraborty S. Brown R et al. An immunohistochemical study of E-cadherin in transitional cell carcinoma and carcinoma in situ in frozen and paraffin sections. J Urol ,1996,155(suppl): 614A.
59. Frixen UH, Behrens J, Sachs M et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol ,1991,113:173-85.
60.李龙承,张旭,陈忠等.E一钙粘连素基因启动子甲基化与该基因表达及前列腺癌病理分级的关系.中华实验外科杂志,2000,17(5): 431-2.
61. Sun W ,Herrera GA. E-cadherin expression in urothelial carcinoma in superficial papillary transitional cell carcinoma, and invasive transitional carcinoma. Hum Pathol, 2002, Oct, 33(10): 996-1000.
62. Rao J, Seligson D, Visapaa H, et al. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer, 2002, Sep 15, 95(6): 1247-57.
63. Popov Z, Gil-Diez de Medina S. Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic infonnation. Br J Cancer ,2000, July, 83(2): 209-14.
64. Byrne RR, Shariat SF, et al. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow up.J Urol, 2001,165(5): 1473-9.
65. Wakatsuki S, watanabe R, et al. Loss of human E-cadherin correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter in urinary bladder. Cancer, 1996, 103:Il-17.
66. Mialhe A, Louis J. Expression of E-cadherin and a-,β-andγ-catenin in human bladder carcinomas: are they good prognostic factors? Invasion Metastasis ,1997, 17:124-37.
67. Li LC, Chui RM, Sasaki M ,et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Research ,2000,60:873-6.
68. Batsche E,Cremisi C .Opposite transcriptional activity between the wild type c-myc gene coding for c-mycland c-myc proteins and c-myc2 separately. Oncogene ,1999,18:5662-5671.
69. Bauer A,Chauvet S,Huber O, et al. Pontin52 and Reptin52 function as antagonistic regulators of p-catenin signaling activity. EMBO J, 2000,19:6121-6130.
70. Battle E,Sancho E,Franci C, et al. The transcription factor Snail is a repressor of e-cadherin gene expression in epithelial tumor cells. Nat Cell Boil, 2000,2:84-89.
71. Cano A,Prtrz-moreno MA,Rodrigo I, et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repression E-cadherin expression. Nat Cell Boil, 2000,2:76-83.
72. Huang GT, Lee HS, Chen CH .Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepatogastroenterolo- gy. 1999,46: 1923-1927.
73. Huber AH,Stewart DB,Laurents DV et al. The cadherin cytoplasmic domain is unstructured in the absence of p-catenin. A possible mechanism for regulating cadherin turnover. J BoilChem. 2001,276 :12301-12309.
74. Noe VFingleton B,Jacobs K et al. Release of an invasion promotor E-cadherin fragment by matrilysin and stromelysin-1 .J Cell Sci 2001,114:111-118.
75. Menke A, Philippi C, Vogelmann R, et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res, 2001, 61:3508-3517.
76.黄菊,程夏楷,杨彬,等.E一钙黏蛋白复合体及其对肿瘤细胞的作用[J].Chemistry of ,2005,25(3):247-250.
77. Foty RA,Steinberg MS.Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy.Int J Dev iol,2004,48 :397-409.
78. Thiery JP.Epithelial-mesenchymal transitions in tumor progression[J].Nat Rev Cancer,2002,2(6):442-454.
79. Li G,Satyamonrthy K,Herlyn M.N-cadherin-mediated intercellular Interactions promote survival and migration of melanoma cells[J]. Cancer Res,2001,61(9): 3819-3825.
80. Thisse B, Met Messal M, Perrin-Sclunitt F. The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern.Nucleic Acids Res, 1987, 15: 3439-3453.
81. Desprez PY, Sumida T, Coppe JP. Helix-loop-helix proteins in mammary gland development and breast cancer.J Mammary Gland Biol Neoplasia, 2003, 8:225-9.
82. Castanon 1, Baylies MK. A Twist in fate: evolutionary comparison of Twist structure and function. Gene, 2002, 287: 11-22.
83. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, et al. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell. 2004, 6(6): 625-30.
84. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999, 13:2207-17.
85. KwokW K, LingM T, Lee TW, et al. Up-regulation of TW IST in prostate cancer and its imp lication as a therapeutic target [ J ].Cancer Res, 2005, 65 (12) : 5153-5162.
86. Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 1999, 13(17): 2207-2217.
87. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br JCancer.2006, 94(1): 13-7.
88. Stasiopoulos IA, Mironchik Y, Raman A, et al. HOXA52twist inter action alters p53 homeostasis in breast cancer cells [ J ]. J Biol Che m, 2005, 280 (3) : 2294-2299.
89. Hamamori Y, SartorelliV, Ogrysko V, et al. Regulation of histone acetyltransferases p300 and PCAF by the bHLH p rotein twist and adenoviral oncop rotein E1A [ J ]. Cell, 1999, 96 (3) : 405-413.
90. Sosic D, Richardson JA, Yu K, et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell. 2003, 112(2): 169-80.
91. Hjiantoniou E, Iseki S, Uney JB, et al. DNazyme-mediated cleavage of Twist transcripts and increase in cellular apoptosis. Biochem Biophys Res Commam. 2003, 300(1): 178-81.
92. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004, 64(15): 5270-82.
93. Rosivatz E, Becker L, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002, 161(5): 1881-91.
94. Watanabe O, Imamura H, Shimizu T, et al. Expression of twist and writ in human breast cancer.Anticancer Res. 2004, 24(6): 3851-6.
95. Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005, 65(12): 5153-62.
96. Martin TA, Goyal A, Watkins G, et al. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 2005, 12(6): 488-96.
97. Sosic D, Richardson JA, Yu K, et al. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell, 2003, 112(2): 169-80.
98. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell,2004,117(7): 927-39.
99. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004. 64(15): 5270-82.
100. Erika Rosivatz, Ingrid Becker, Katja Specht, et al. Differential expression of the Epithelial-Mesenchymal Transition Regulators Snail, SIPl,and Twist in Gastric Cancer. Am J Pathol, 2002,161:1881-1891.
101. Bialek P, Kern B, Yang X, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell. 2004, 6(3): 423-35.
102. Tamura M, Noda M. Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. J Cell Biochem. 1999, 72(2): 167-76.
103. Villavicencio EH, Yoon JW, Frank DJ, et al. Cooperative E-box regulation of human GLII by TWIST and USF. Genesis, 2002, 32: 247-58.
104. Maestro R, Dei 'fos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev, 1999,13;2207-2217.
105.王其,陈效平,关剑,等.Twist基因表达与肝癌多耐药细胞侵袭的相关性研究【J】.肝胆外科杂志,2006,14(1):66-68.
106. Wang X, Ling MT, Guan XY, et al. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene, 2004, 23: 474-82.
107. Puisieux A, Valsesia2Wittmann S, Ansieau S, et al. A twist for survival and cancer p rogression[J]. Br J Cancer, 2006, 94 ( 1 ) :13217.
108. Elias MC, Tozer KR, Silber JR, et al. TWIST is expressed in human gliomas and promotes invasion.Neoplasia.2005, 7(9): 824-37.
109. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat.(Basel), 1995, 154: 8-20
110. Thiery JP. Epithelial-mesenchymal transitions in tumour progressi on.Nat Rev Cancer, 2002, 2: 442-454.
111. Rosivatz E, Becker I, Specht K, et al. Differential exp ression of the epithelial mesenchymal transition regulators snail, SIP1, and twist in gastric cancer[ J ]. Am J Pathol, 2002, 161 (5): 1881-18 91.
112. Castanon I, BayliesM K. A Twist in fate: evolutionary comparison of Twist structure and function [ J ]. Gene, 2002, 287 ( 122 ) :11- 22.
113. Sosic D, Richardson J A, Yu K, et al. Twist regulate cytokine gene expression through a negative feedback loop that rep resses NF-κB activity[ J ]. Cell, 2003, 112 (2) : 169-180.
114. Karreth F,Tuveson DA.Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis[J].Cancer Biol Ther,2004,3(11):1058-1059.
115. Watanabe O,Imamura H,Shimizu T,et a1.Expression of twist andwnt in human breast cancer[J].Anticancer Res,2004,24(6):3851- 3856.
116. Vernon AE,LaBonne C.Tumor Metastasis:A new twist on Epithelial-mesenchymal transition.Curr Biol.2004,14:719-721.
117. Martin TA,Goyal Watkins G,et a1.Expression of the transeription factors snail,slug,and twist and their clinical significance in human breast cancer[J].Ann Surg Omol,2005,12(6):488-96.